Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.22.4
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of time based stock options

    December 31, 2022   December 31, 2021  
               
Dividend yield     0.00%     0.00%  
Expected volatility     65.29% – 77.5%     74.0177.91%  
Weighted-average volatility          
Expected dividends          
Expected term (in years)     10 Years     10 Years  
Risk-free rate     1.814.02%     1.201.62%  
Schedule of status of time based stock options

The following table summarizes the status of the Company’s stock option plan:

 

    December 31, 2022   December 31, 2021  
    Shares   Weighted
Average
Exercise
Price
  Shares   Weighted
Average
Exercise
Price
 
                   
Outstanding at January 1     3,672,500   $ 3.42     2,922,494   $ 2.46  
Granted     445,000   $ 2.57     2,000,000   $ 3.64  
Exercised     1,031,250   $ 1.57     1,062,500   $ 1.19  
Forfeited     526,250   $ 2.73     187,494   $ 3.36  
Outstanding at year end     2,560,000   $ 4.15     3,672,500   $ 3.42  
Options exercisable     737,500   $ 4.93     983,750   $ 2.73  
Weighted average fair value of options granted during the period       $ 1.98       $ 2.85  
Stock-based compensation expense       $ 1,925,861       $ 2,457,788  
Schedule of information pertaining to options outstanding

The following table presents information pertaining to options outstanding as of December 31, 2022:

 

Range of Exercise Price   Number
Outstanding
  Weighted
Average
Remaining
Contractual
Life
  Weighted
Average
Exercise
Price
  Number
Exercisable
  Weighted
Average
Exercise
Price
 
                           
$2.25 - $9.49   2,560,000   8.8 years   $ 4.15   737,500   $ 4.93  
Schedule of time based stock options

 

    December 31,  
    2022   2021  
               
Dividend yield     0.00%     0.00%  
Expected Volatility     65.9%     0% – 0%  
Weighted-average volatility          
Expected dividends          
Expected term (in years)     10     0  
Risk-free rate     2.99%     0% – 0%  
Schedule of status of time based stock options

The following table summarizes the status of the 2021 Plan with respect to time based stock options:

 

    Year Ended December 31,  
    2022   2021  
    Shares   Weighted
Average
Exercise
Price
  Shares   Weighted
Average
Exercise
Price
 
                   
Outstanding at January 1   0   $ 0       $  
Granted   475,000   $ 2.67       $  
Exercised   0   $       $  
Forfeited   0   $       $  
Outstanding at year end   475,000   $ 2.67       $  
Options exercisable   0   $       $  
Weighted average fair value of options granted during the period     $ 1.99       $  
Stock-based compensation expense     $ 157,536       $  
Schedule of information pertaining to options outstanding

The following table presents information pertaining to options outstanding at December 31, 2022:

 

Range of Exercise Price   Number
Outstanding
  Weighted
Average
Remaining
Contractual
Life
  Weighted
Average
Exercise
Price
  Number
Exercisable
  Weighted
Average
Exercise
Price
 
                           
$2.67   475,000   9.3 years   $ 2.67   0   $ 0  
Schedule of performance base options outstanding

The following table summarizes the status of the 2015 Plan with respect to performance-based stock options as of December 31, 2022 and 2021:

 

    December 31, 2022     December 31, 2021  
    Shares   Weighted
Average
Exercise
Price
    Shares   Weighted
Average
Exercise
Price
 
                     
Outstanding at January 1     $       1,000,000   $ 1.70  
Granted     $         $  
Exercised     $         $  
Forfeited     $         $  
Outstanding at year end     $       1,000,000   $ 1.70  
Options exercisable     $         $  
Weighted average fair value of options granted during the period     $         $  
Stock-based compensation expense     $         $ (408,747 )
The following table summarizes the activities for our unvested restricted stock awards for the twelve months ended December 31, 2022, and 2021.

 

    Twelve Months Ended December 31,  
    2022   2021  
    Shares   Weighted
Average
Grant-Date Fair Value
  Shares   Weighted
Average
Grant-Date Fair Value
 
                   
Unvested at January 1   1,000,000   $ 3.01     $  
Granted     $   1,000,000   $ 3.01  
Vested   50,000   $ 3.31     $  
Forfeited/canceled     $     $  
Unvested at December 31   950,000   $ 3.04   1,000,000   $ 3.01